Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
1961 or 1962 (age 62–63) [1] South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen.
AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.69% and 0.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Better-than-expected performance at Pharmaceutical Distribution and World Courier and higher revenues might aid AmerisourceBergen (ABC) in Q2 earnings. However, stiff competition might be a dampener.
PharMerica. PharMerica is a Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare 's pharmacy business with a subsidiary of AmerisourceBergen. [1] The company is headquartered in Louisville, Kentucky, and operates a major customer support center in Tampa, Florida. [2]
AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to be driven by its core Pharmaceutical Distribution business despite a competitive industry.